FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia  | Date: 2021-02-24

FDA to allow pharma companies modify COVID-19 shots amid variants surge

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the disease.

The FDA guidance introduced recently is specifically for companies making COVID-19 diagnostic, therapeutics, and vaccines, cited sources with relevant information.

As evidence suggests, Pfizer-BioNTech and Moderna’s COVID-19 doses, which have been approved for use in the United States, appear to offer protection against the new variants. However, with the virus continuing to mutate, pharma companies are required to adapt quickly to the evolving variants.

FDA’s newly issued groundwork will allow drug makers to react quickly to the emerging COVID-19 variants without the need for extended clinical trials to prove effectiveness and safety each time a new variant is discovered.

It is worth noting that the new development is similar to the flu shot changes that occur from year to year.

According to the Director of FDA’s Center for Biologics Evaluation and Research, Dr. Peter Marks, since flu shot is well studied, it is unnecessary to conduct clinical trials each year. He further claimed that drug manufacturers usually modify the shots based on the current strains that are likely to be in circulation.

Apart from having additional safety data, it is critical to understand whether the new vaccine can cover both the old as well as the new strain, Marks added. If the vaccine strain shows to be consistent, then the FDA could move towards the influenza-like model.

The new FDA guidelines also recommend producers of COVID-19 diagnostic tests as well as antibody treatment options to understand how emerging variants could impact their relevant effectiveness.

The U.S. Centers for Disease Control and Prevention may also relax some of its COVID-19 precautionary measures which were aimed at reducing the spread of the disease, sources claimed.

Source Credits –

https://www.nbcnews.com/health/health-news/fda-says-covid-vaccine-makers-can-modify-shots-variants-emerge-n1258528

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

WeWork India rectifies glitch that revealed visitors’ personal data

WeWork India rectifies glitch that revealed visitors’ personal data

By Nikita Chaurasia

WeWork Inc., a flexible workspace solutions company, has reportedly corrected a security flaw that gave unrestrained access to the personal details and selfies of several users who visited its coworking spaces. Sandeep Hodkasia, a security consult...

China’s Great Wall Motor suspends USD 1 Bn investment plan in India

China’s Great Wall Motor suspends USD 1 Bn investment plan in India

By Nikita Chaurasia

After failing to get regulatory permits, China's Great Wall Motor has reportedly abandoned its plans to invest USD 1 billion in India and has fired all employees from its Indian facilities. The Chinese automaker had planned to penetrate the India...

Walmart to double down on frictionless optical care with Memomi buyout

Walmart to double down on frictionless optical care with Memomi buyout

By Nikita Chaurasia

Walmart Inc. is reportedly planning to acquire the augmented reality optical tech firm Memomi, reflecting the retailer’s commitment to offering frictionless and omnichannel optical care. The buyout could potentially allow Walmart to offer a fun...

Google faces antitrust lawsuit from Danish job search entity Jobindex

Google faces antitrust lawsuit from Danish job search entity Jobindex

By Nikita Chaurasia

Google LLC was reportedly hit with an antitrust case by Jobindex, a Danish online job-search rival, that took its grievance to European regulators asserting that Alphabet Inc.’s subsidiary is unjustly favoring its job-search engine. The comp...

EU vows USD 630 Mn aid to vulnerable countries amidst Ukraine-conflict

EU vows USD 630 Mn aid to vulnerable countries amidst Ukraine-conflict

By Nikita Chaurasia

The European Union has reportedly pledged USD 630 million to support weaker nations to tackle food scarcity that was made worse by Russia's assault on Ukraine. The funds include USD 368 million in aid to increase long-term sustainable food produc...